Recently, I found an article titled “Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy.” that originally appeared in the December 2009 edition of American Journal of Obstetrics and Gynecology. Published by R. Calderon-Margalit and a team from The University of Washington School of Public Health and Community Medicine (Seattle, WA), this article further explored the link between exposure to selective serotonin reuptake inhibitor drugs (SSRIs) and poor birth outcomes.
The team’s stated objective was “to determine the association of maternal psychotropic medication use during pregnancy with preterm delivery and other adverse perinatal outcomes.”
For this study, “A cohort of 2793 pregnant women in Washington State was interviewed, and their medical files were abstracted. After statistical analyses were performed, results showed that “Maternal use of benzodiazepine during pregnancy was associated with an increased risk of preterm delivery (adjusted odds ratio, 6.79; 95% confidence interval, 4.01-11.5) and with increased risks of low birthweight, low Apgar score, neonatal intensive care unit admissions, and respiratory distress syndrome. Selective serotonin receptor inhibitors were associated with preterm deliveries only among women who started treatment after the first trimester.”
Since most women use SSRIs in pregnancy unaware of the risk for preterm delivery due to the manufacturer’s failure to warn, thousands of SSRI birth defect lawsuits are currently being filed around the world.
If you or a loved one used SSRIs and gave birth to a child with a birth defect or who was born prematurely, your family may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of SSRI birth defect lawyers at the information provided below. We have the compassion, experience, and resources required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529